Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 103 clinical trials
None
MEOI and HRQoL in CLL Patients Treated With BTKis

the Bruton's tyrosine kinase inhibitors (BTKi) acalabrutinib or ibrutinib in the United States (US).

acalabrutinib
monoclonal antibodies
monoclonal protein
ibrutinib
lymphoma
  • 0 views
  • 07 Dec, 2021
  • 15 locations
None
Assessment of the Quality of Life of Patients With Lymphomas Treated With Oral Therapy

receive oral therapy at home. Ibrutinib, acalabrutinib, idelalisib, venetoclax and lenalidomide are oral therapies used in the treatment of Chronic Lymphoid Leukemia, Follicular Lymphoma, Waldenstrm's

  • 0 views
  • 11 Aug, 2021
  • 1 location
None
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia

therapies (e.g. ibrutinib, acalabrutinib) or combined immuno-chemotherapy regimens (e.g., fludarabine, cyclophosphamide, and rituximab for patients aged <65 years without del17p/TP53 mutations or

cyclophosphamide
bendamustine
fludarabine
TP53
ibrutinib
  • 0 views
  • 01 Oct, 2021
  • 2 locations